Study: Novel agent decreases neuropathic pain in patients with type 2 diabetes

A promising profile of disease modification and pain reduction leads to proof-of-concept trials. —> Read More Here

facebooktwittergoogle_plusredditpinterestlinkedinmail

Leave a Reply

Your email address will not be published. Required fields are marked *